IONS
NASDAQ · Biotechnology
Ionis Pharmaceuticals Inc
$38.80
-1.35 (-3.36%)
Performance
1D
—
1W
-10.85%
1M
-12.14%
3M
-31.86%
6M
-48.53%
1Y
-47.64%
YTD
-51.30%
Open$40.31
Previous Close$40.15
Day High$40.50
Day Low$38.31
52W High$86.74
52W Low$42.08
Volume—
Avg Volume2.67M
Market Cap7.23B
P/E Ratio—
EPS$-3.47
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$47.75
Below
SMA 200
$66.24
Below
RSI (14)
34.5
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
31 analysts
Price Target
+93.1% upside
Current
$38.80
$38.80
Target
$74.94
$74.94
$58.43
$74.94 avg
$113.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 979.90M | 836.66M | 6.52B |
| Net Income | -396,009,323 | -304,310,442 | -1,853,302,223 |
| Profit Margin | -40.4% | -38.4% | -28.4% |
| EBITDA | -385,924,253 | -313,036,236 | -2,518,216,651 |
| Free Cash Flow | — | — | -1,126,512,375 |
| Rev Growth | +17.1% | +17.1% | -9.9% |
| Debt/Equity | 4.77 | 4.77 | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |